USANA Health Sciences’ China Subsidiary, BabyCare Ltd., Receives Approval for Eight Additional Direct Selling Licenses in M...
13 5월 2016 - 2:15AM
Business Wire
USANA Health Sciences Inc. (NYSE: USNA), a global nutritional
company, announced today that its China subsidiary, BabyCare Ltd.,
received approval from the Ministry of Commerce People’s Republic
of China (MOFCOM) to expand direct selling activities in eight
additional provinces/municipalities within China. The
provinces/municipalities are Liaoning Province, Shandong Province,
Shanxi Province, Sichuan Province, Guangdong Province, Dalian City,
Qingdao City, and Shenzhen City. These additional licenses add to
BabyCare’s existing direct selling licenses in the
municipalities/provinces of Beijing, Jiangsu, Shanxi and
Tianjin.
“We are pleased to have received these additional licenses in
China, where we continue to expand the reach of our world-class
products,” said Co-CEO Dave Wentz. “We remain committed to working
with the Chinese government as we continue growing our business in
this promising market.”
For more information about USANA’s products and company, visit
USANA.com.
About USANA
USANA develops and manufactures high-quality nutritional
supplements, healthy foods and personal care products that are sold
directly to Associates and Preferred Customers throughout the
United States, Canada, Australia, New Zealand, Hong Kong, China,
Japan, Taiwan, South Korea, Singapore, Mexico, Malaysia, the
Philippines, the Netherlands, the United Kingdom, Thailand, France,
Belgium, Colombia and Indonesia. More information on USANA can be
found at http://www.usanahealthsciences.com.
Safe Harbor
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act and Section 21E of
the Securities Exchange Act. Our actual results could differ
materially from those projected in these forward-looking
statements, which involve a number of risks and uncertainties,
including global economic conditions generally, reliance upon our
network of independent Associates, the governmental regulation of
our products, manufacturing and marketing risks, adverse publicity
risks, and risks associated with our international expansion. The
contents of this release should be considered in conjunction with
the risk factors, warnings, and cautionary statements that are
contained in our most recent filings with the Securities and
Exchange Commission.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160512006300/en/
USANA Health Sciences, Inc.Investors Contact:Patrique Richards,
801-954-7961Director of Investor
Relationsinvestor.relations@us.usana.comorMedia Contact:Dan Macuga,
801-954-7280Chief Communications
Officermedia(at)us.usana(dot)comorMedia Contact:Ashley Collins,
801-954-7629Executive Director of PR, Social Media and
Communicationsmedia(at)us.usana(dot)com
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024